Vertex Pharmaceuticals, Inc.

NASDAQ:VRTX   12:49:49 PM EDT
217.08
+2.73 (+1.27%)
Products

Moderna And Vertex Establish New Collaboration To Treat Cystic Fibrosis Using Gene Editing

Published: 09/16/2020 21:42 GMT
Vertex Pharmaceuticals, Inc. (VRTX) - Moderna and Vertex Establish New Collaboration to Treat Cystic Fibrosis Using Gene Editing.
Moderna Inc - Second Collaboration Between Moderna and Vertex Based on Moderna's Proprietary Mrna and Lnp Technology.
Moderna Inc - Moderna to Receive $75 Million Upfront, With Potential for Additional Development, Regulatory and Commercial Milestones and Royalty Payments.
Moderna Inc - Eligible to Receive Up to $380 Million in Development, Regulatory and Commercial Milestones, Plus Royalties From Collaboration With Vertex.
Moderna - Three-year Research Collaboration With Vertex Initially to Focus on Discovery and Optimization of Novel Lnps and Mrnas.